These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16441223)

  • 1. A new therapeutic target for atherosclerosis treatment: interview with Uday Saxena. Interviewed by Emma Quigley.
    Saxena U
    Expert Opin Ther Targets; 2006 Feb; 10(1):1-3. PubMed ID: 16441223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Servier in oncology: bringing innovation to patients.
    Bertrand CP
    Future Oncol; 2019 Jul; 15(19):2191-2197. PubMed ID: 31146594
    [No Abstract]   [Full Text] [Related]  

  • 3. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current targets in irritable bowel syndrome: an interview with Eamonn Quigley. Interview by Emma Quigley.
    Quigley E
    Expert Opin Ther Targets; 2006 Jun; 10(3):351-3. PubMed ID: 16706675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic potential of CD39: interview with Dr Simon Robson by Emma Quigley.
    Robson S
    Expert Opin Ther Targets; 2006 Oct; 10(5):649-52. PubMed ID: 16981822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of vasoactive intestinal peptide in neuroprotection: Professor Illana Gozes is interviewed by Emma Quigley.
    Gozes I
    Expert Opin Ther Targets; 2007 Jun; 11(6):733-6. PubMed ID: 17504011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Navigating the clinical trial pathway: Conception, design, execution, and results dissemination.
    Sampalis JS; Watson J; Boukas S; Boukas M; Harvey N; Machado S; Bordeleau M; Rampakakis E
    Surgery; 2017 Mar; 161(3):576-583. PubMed ID: 28190508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in immunotherapy for melanoma.
    Ascierto PA; Larkin J
    Melanoma Manag; 2014 Aug; 1(1):19-24. PubMed ID: 30190806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The making of a lipid biochemist.
    Choy PC
    Clin Invest Med; 2018 Nov; 41():26-28. PubMed ID: 30394277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
    Høilund-Carlsen PF
    Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell adhesion molecules as therapeutic targets: interview with Professor Michael P Schön. Interviewed by Emma Quigley.
    Schön MP
    Expert Opin Ther Targets; 2006 Dec; 10(6):799-802. PubMed ID: 17105368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of late professor T. C. Tung to the experimental embryology of Amphioxus. In memory of the 20th anniversary of Professor T. C. Tung's death.
    Yan S
    Dev Growth Differ; 1999 Oct; 41(5):503-22. PubMed ID: 10545024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interview: Discussions on the development of human embryonic stem cell-based therapies.
    Lebkowski JS
    Regen Med; 2009 Sep; 4(5):659-61. PubMed ID: 19761390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3--a promising therapeutic target: Dr Hagit Eldar-Finkelman interviewed by Emma Quigley.
    Eldar-Finkelman H
    Expert Opin Ther Targets; 2006 Apr; 10(2):199-201. PubMed ID: 16548769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting angiogenesis: interview with Dr Jean Plouët. Interview by Emma Quigley.
    Plouët J
    Expert Opin Ther Targets; 2006 Aug; 10(4):501-3. PubMed ID: 16848687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interview: An evolving career in personalized medicine: an interview with Dr Paul Billings.
    Billings P
    Per Med; 2012 May; 9(3):253-257. PubMed ID: 29758789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centenary of the Birth of Academician Prof. Dr. Isak Tadzer, Founder of the Pathophysiology and Nuclear Medicine in Macedonia.
    Karanfilski B
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Sep; 38(2):9-17. PubMed ID: 28991760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenges and future of oral drug delivery: An interview with David Brayden.
    Brayden DJ
    Ther Deliv; 2016 Dec; 7(12):791-794. PubMed ID: 27824287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming the diagnosis of tuberculosis: an editorial board member's opinion at the 15th year of Expert Review of Molecular Diagnostics.
    Pai M; Raison C
    Expert Rev Mol Diagn; 2015 Mar; 15(3):295-8. PubMed ID: 25656154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interview: commercial translation of cell-based therapies and regenerative medicine: learning by experience. Interview by Emily Culme-Seymour.
    Haseltine WA
    Regen Med; 2011 Jul; 6(4):431-5. PubMed ID: 21749201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.